As per GOI’s circular on price-capping of stents by NPPA(National Pharmaceutical Pricing Authority), new prices of coronary stents have been implemented effective 14th February, 2017. For details on stent pricing, across our hospitals. CLICK HERE

Media Room

Fortis Healthcare to acquire 51% Economic Interest in Fortis Hospotel Limited (FHTL), an RHT Subsidiary

Date : February 04, 2016

Fortis Healthcare Limited today announced that its Board of Directors have approved the acquisition of a 51% economic interest in Fortis Hospotel Limited (FHTL), a subsidiary of the Religare Health Trust (RHT). The RHT is a business trust listed on the SGX of which Fortis is a sponsor with a 28% equity stake. It comprises a portfolio of 12 clinical establishments, four greenfield clinical establishments and two operating hospitals in India.

Read Full Press Release

PrintCopy TextGo Back